Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole for Six Candida Species as Determined by the Colorimetric Sensititre YeastOne Method
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole for Six Candida Species as Determined by the Colorimetric Sensititre YeastOne Method
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL MICROBIOLOGY
Volume 51, Issue 8, Pages 2691-2695
Publisher
American Society for Microbiology
Online
2013-06-13
DOI
10.1128/jcm.01230-13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey
- (2012) J. Peman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution
- (2012) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Comparison of Three Statistical Methods for Establishing Tentative Wild-Type Population and Epidemiological Cutoff Values for Echinocandins, Amphotericin B, Flucytosine, and Six Candida Species as Determined by the Colorimetric Sensititre YeastOne Method
- (2012) E. Canton et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Prospective Multicenter Study of the Epidemiology, Molecular Identification, and Antifungal Susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Isolated from Patients with Candidemia
- (2011) Emilia Cantón et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Transcriptional Profiling of Azole-Resistant Candida parapsilosis Strains
- (2011) A. P. Silva et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
- (2011) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Triazole and Echinocandin MIC Distributions with Epidemiological Cutoff Values for Differentiation of Wild-Type Strains from Non-Wild-Type Strains of Six Uncommon Species ofCandida
- (2011) Michael A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methods
- (2010) M.A. Pfaller et al. DRUG RESISTANCE UPDATES
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for Posaconazole and Voriconazole and Candida spp. as Determined by 24-Hour CLSI Broth Microdilution
- (2010) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Normalized Resistance Interpretation as a Tool for Establishing Epidemiological MIC Susceptibility Breakpoints
- (2010) Göran Kronvall JOURNAL OF CLINICAL MICROBIOLOGY
- Echinocandin Susceptibility Testing of Candida Species: Comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, Disk Diffusion, and Agar Dilution Methods with RPMI and IsoSensitest Media
- (2009) M. C. Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
- (2009) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- Ibuprofen reverts antifungal resistance onCandida albicansshowing overexpression of CDR genes
- (2009) Elisabete Ricardo et al. FEMS YEAST RESEARCH
- Epidemiological Cutoffs and Cross-Resistance to Azole Drugs in Aspergillus fumigatus
- (2008) J. L. Rodriguez-Tudela et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started